Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Troglitazone | hsa00040 | Pentose and glucuronate interconversions | 2.33E-04 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Troglitazone | hsa00061 | Fatty acid biosynthesis | 1.52E-03 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa00071 | Fatty acid degradation | 4.55E-03 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa00220 | Arginine biosynthesis | 1.50E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Troglitazone | hsa00280 | Valine, leucine and isoleucine degradation | 3.30E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Troglitazone | hsa00520 | Amino sugar and nucleotide sugar metabolism | 7.87E-03 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Troglitazone | hsa00561 | Glycerolipid metabolism | 2.62E-02 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Troglitazone | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 4.30E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Troglitazone | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | | Troglitazone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.00E-02 | 1 | P09211 | GSTP1 | More | | Troglitazone | hsa00983 | Drug metabolism - other enzymes | 1.63E-02 | 2 | P20839, Q16772 | IMPDH1, GSTA3 | More | | Troglitazone | hsa01100 | Metabolic pathways | 5.84E-03 | 44 | P35790, P05089, Q16772, Q9UJ14, P30041, P15104, O14986, P48426, Q14642, Q96DU7, P07195, Q08828, Q02153, P20839, O94777, Q16875, O43286, O43451, P15121, Q86XP1, O95861, P14550, Q14739, Q9UHK6, P11511, Q86VZ5, Q08477, P15907, Q9UNP4, Q9H4F1, P32321, P60891, P49448, P15586, P00352, Q9BPW9, P43490, P46976, P05166, P13073, P05496, O15239, O15047, Q9NVH6 | CHKA, ARG1, GSTA3, GGTL3, PRDX6, GLUL, PIP5K1B, PIP4K2A, INPP5A, ITPKC, LDHB, ADCY1, GUCY1B3, IMPDH1, DPM2, PFKFB3, B4GALT5, MGAM, AKR1B1, DGKH, BPNT1, AKR1A1, LBR, AMACR, CYP19A1, SGMS1, CYP4F3, ST6GAL1, ST3GAL5, ST6GALNAC4, DCTD, PRPS1, GLUD2, GNS, ALDH1A1, DHRS9, PBEF1, GYG1, PCCB, COX4I1, ATP5G1, NDUFA1, SETD1A, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16772 | GSTA3 | Glutathione S-transferase A3 | P35790 | CHKA | Choline kinase alpha | 0.74 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05089 | ARG1 | Arginase-1 | 0.826 | Q16772 | GSTA3 | Glutathione S-transferase A3 | Q16772 | GSTA3 | Glutathione S-transferase A3 | 1 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.769 | Q16772 | GSTA3 | Glutathione S-transferase A3 | P30041 | PRDX6 | Peroxiredoxin-6 | -0.788 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15104 | GLUL | Glutamine synthetase | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O14986 | PIP5K1B | Phosphatidylinositol 4-phosphate 5-kinase type-1 beta | 0.806 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.725 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14642 | INPP5A | Inositol polyphosphate-5-phosphatase A | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q96DU7 | ITPKC | Inositol-trisphosphate 3-kinase C | -0.816 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P07195 | LDHB | L-lactate dehydrogenase B chain | -0.75 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.785 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.714 | Q16772 | GSTA3 | Glutathione S-transferase A3 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | -0.768 | Q16772 | GSTA3 | Glutathione S-transferase A3 | O94777 | DPM2 | Dolichol phosphate-mannose biosynthesis regulatory protein | -0.723 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.834 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.861 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O43451 | MGAM | Maltase-glucoamylase | 0.745 | Q16772 | GSTA3 | Glutathione S-transferase A3 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | -0.793 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.757 | Q16772 | GSTA3 | Glutathione S-transferase A3 | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | 0.7 | Q16772 | GSTA3 | Glutathione S-transferase A3 | P14550 | AKR1A1 | Aldo-keto reductase family 1 member A1 | -0.706 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q14739 | LBR | Delta(14)-sterol reductase LBR | 0.73 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.736 | Q16772 | GSTA3 | Glutathione S-transferase A3 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | 0.787 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P11511 | CYP19A1 | Aromatase | -0.706 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.733 | Q16772 | GSTA3 | Glutathione S-transferase A3 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.907 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.832 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.936 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9H4F1 | ST6GALNAC4 | Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase | 0.758 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P32321 | DCTD | Deoxycytidylate deaminase | -0.774 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | -0.769 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | -0.895 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P15586 | GNS | N-acetylglucosamine-6-sulfatase | 0.716 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | -0.808 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.821 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.749 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P46976 | GYG1 | Glycogenin-1 | 0.845 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05166 | PCCB | Propionyl-CoA carboxylase beta chain, mitochondrial | 0.781 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.713 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.714 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.745 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | O15047 | SETD1A | Histone-lysine N-methyltransferase SETD1A | 0.809 | P30740 | SERPINB1 | Leukocyte elastase inhibitor | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.719 | Q16772 | GSTA3 | Glutathione S-transferase A3 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | 0.736 |
| Troglitazone | hsa01212 | Fatty acid metabolism | 7.59E-03 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa01524 | Platinum drug resistance | 1.79E-02 | 2 | O15392, P11388 | BIRC5, TOP2A | More | | Troglitazone | hsa03010 | Ribosome | 2.25E-04 | 5 | P40429, Q07020, P27635, P05386, P62249 | RPL13A, RPL18, RPL10, RPLP1, RPS16 | More | | Troglitazone | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Troglitazone | hsa03320 | PPAR signaling pathway | 4.38E-03 | 3 | Q6PCB7, Q9UKU0, Q9UNU6 | SLC27A1, ACSL6, CYP8B1 | More | | Troglitazone | hsa04060 | Cytokine-cytokine receptor interaction | 4.33E-02 | 11 | P27930, P14778, P01584, Q13651, Q9HBE5, Q9UBD3, P47992, P09341, P32248, P18510, P01730 | IL1R2, IL1R1, IL1B, IL10RA, IL21R, XCL2, XCL1, CXCL1, CCR7, IL1RN, CD4 | More | | Troglitazone | hsa04071 | Sphingolipid signaling pathway | 2.08E-02 | 6 | P17252, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | PRKCA, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Troglitazone | hsa04114 | Oocyte meiosis | 4.51E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Troglitazone | hsa04146 | Peroxisome | 1.37E-02 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa04151 | PI3K-Akt signaling pathway | 2.51E-02 | 16 | P21860, P43657, P01106, P27348, O14944, Q9GZP0, P07900, P62873, P50151, P13612, P26012, P24821, Q16363, P22105, Q99941, P18848 | ERBB3, P2RY5, MYC, YWHAQ, EREG, PDGFD, HSP90AA1, GNB1, GNG10, ITGA4, ITGB8, TNC, LAMA4, TNXB, CREBL1, ATF4 | More | | Troglitazone | hsa04216 | Ferroptosis | 1.52E-02 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa04370 | VEGF signaling pathway | 2.47E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Troglitazone | hsa04512 | ECM-receptor interaction | 4.68E-02 | 5 | Q16363, P24821, P22105, P13612, P26012 | LAMA4, TNC, TNXB, ITGA4, ITGB8 | More | | Troglitazone | hsa04613 | Neutrophil extracellular trap formation | 2.33E-02 | 12 | P17252, O60603, P05164, P08246, Q6FI13, P68431, Q15080, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, H2AC18; H2AC19, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Troglitazone | hsa04640 | Hematopoietic cell lineage | 6.74E-03 | 10 | P13612, P14778, P27930, P25063, P07766, P09693, P01732, P01730, P13765, P01584 | ITGA4, IL1R1, IL1R2, CD24, CD3E, CD3G, CD8A, CD4, HLA-DOB, IL1B | More | | Troglitazone | hsa04650 | Natural killer cell mediated cytotoxicity | 3.08E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | | Troglitazone | hsa04658 | Th1 and Th2 cell differentiation | 3.62E-04 | 11 | Q04759, P07766, P20963, P09693, P01730, P06239, P23771, Q9UL17, P46531, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, GATA3, TBX21, NOTCH1, HLA-DOB, RUNX3 | More | | Troglitazone | hsa04659 | Th17 cell differentiation | 8.31E-05 | 13 | Q04759, P01730, P06239, P13765, P14778, Q9HBE5, Q9UL17, P23771, P01584, P07900, P07766, P09693, P20963 | PRKCQ, CD4, LCK, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, IL1B, HSP90AA1, CD3E, CD3G, CD247 | More | | Troglitazone | hsa04660 | T cell receptor signaling pathway | 4.36E-03 | 10 | Q04759, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239 | PRKCQ, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK | More | | Troglitazone | hsa04666 | Fc gamma R-mediated phagocytosis | 2.66E-02 | 5 | O75015, P06396, O14494, Q9UQC2, P17252 | FCGR3B, GSN, PLPP1, GAB2, PRKCA | More | | Troglitazone | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Troglitazone | hsa04714 | Thermogenesis | 3.64E-02 | 1 | Q9UKU0 | ACSL6 | More | | Troglitazone | hsa04720 | Long-term potentiation | 2.35E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Troglitazone | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.28E-02 | 6 | P14778, P01584, Q08828, Q13557, P24723, Q04759 | IL1R1, IL1B, ADCY1, CAMK2D, PRKCH, PRKCQ | More | | Troglitazone | hsa04912 | GnRH signaling pathway | 3.30E-02 | 4 | P17252, Q16539, Q9Y6R4, Q14643 | PRKCA, MAPK14, MAP3K4, ITPR1 | More | | Troglitazone | hsa04914 | Progesterone-mediated oocyte maturation | 7.70E-03 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Troglitazone | hsa04920 | Adipocytokine signaling pathway | 4.85E-03 | 3 | Q9UKU0, Q9Y478, Q96RR4 | ACSL6, PRKAB1, CAMKK2 | More | | Troglitazone | hsa04934 | Cushing syndrome | 2.63E-02 | 6 | Q99941, P18848, Q08828, O15169, Q13557, O00170 | CREBL1, ATF4, ADCY1, AXIN1, CAMK2D, AIP | More | | Troglitazone | hsa05135 | Yersinia infection | 2.58E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Troglitazone | hsa05146 | Amoebiasis | 7.62E-03 | 9 | P01584, Q16363, P09341, P14778, P27930, P05089, Q08828, P12814, P08311 | IL1B, LAMA4, CXCL1, IL1R1, IL1R2, ARG1, ADCY1, ACTN1, CTSG | More | | Troglitazone | hsa05170 | Human immunodeficiency virus 1 infection | 4.37E-02 | 4 | Q02750, P62879, P16298, Q05397 | MAP2K1, GNB2, PPP3CB, PTK2 | More | | Troglitazone | hsa05171 | Coronavirus disease - COVID-19 | 3.87E-04 | 5 | P62249, P40429, P27635, Q07020, P05386 | RPS16, RPL13A, RPL10, RPL18, RPLP1 | More | | Troglitazone | hsa05202 | Transcriptional misregulation in cancer | 1.75E-02 | 12 | Q15532, P14780, P27930, Q16548, Q13489, Q13077, P35226, P05164, P08246, P41182, P68431, P24522 | SS18, MMP9, IL1R2, BCL2A1, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL6, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, GADD45A | More | | Troglitazone | hsa05204 | Chemical carcinogenesis | 4.00E-02 | 1 | P09211 | GSTP1 | More | | Troglitazone | hsa05217 | Basal cell carcinoma | 3.30E-02 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Troglitazone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.83E-02 | 7 | O95267, P07766, P20963, P09693, P06239, Q04759, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, PRKCQ, CD4 | More | | Troglitazone | hsa05321 | Inflammatory bowel disease | 4.68E-02 | 5 | P13765, Q9UL17, P23771, P01584, Q9HBE5 | HLA-DOB, TBX21, GATA3, IL1B, IL21R | More | | Troglitazone | hsa05340 | Primary immunodeficiency | 3.99E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Troglitazone | hsa05415 | Diabetic cardiomyopathy | 3.07E-02 | 7 | P17252, Q15080, Q16718, O14521, Q16539, P49841, P14780 | PRKCA, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, MMP9 | More | | |